The Centers for Medicare & Medicaid Services late today released new guidance to help surveyors identify when to cite health care providers or suppliers for violations of health and safety regulations that cause serious harm or death to a patient.
News
Latest
The rate of hospital-onset methicillin-resistant staphylococcus aureus bloodstream infections declined 17.1 percent per year between 2005 and 2012, but did not change significantly between 2013 and 2016.
The Senate Health, Education, Labor and Pensions Committee today held a hearing
Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced that he will step down in about a month.
Five hospitals and five payers are participating in the first year of the Pennsylvania Rural Health Model, a multi-payer global budget model for rural critical access and acute-care hospitals in the state.
The ongoing outbreak of Ebola virus disease in the Democratic Republic of Congo serves as a reminder for U.S. health care facilities to review their infection prevention and control processes to safely identify and manage patients with communicable infections.
A panel commissioned by the American Board of Medical Specialties to review the continuing certification process recently released a report on its findings and recommendations.
The AHA, along with Baxter International Foundation and the Health Research & Educational Trust, is accepting applications through April 5 for the 2019 Foster G. McGaw Prize.
All around us, we see exciting examples of bold thinking and experimentation to better serve patients. Already, many of these new models and methods are achieving positive results.
The Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use would appropriately improve the safety and efficacy of the devices while recognizing their vital role in hospitals and health systems, AHA said in comments submitted yesterday.
The Centers for Medicare & Medicaid Services has released updated resources intended to clarify whether a hospital outreach laboratory qualifies as an “applicable laboratory” under the Medicare Clinical Laboratory Fee Schedule and detailing related requirements for collecting and reporting private-payer rate clinical laboratory test payment and volume data.
The Food and Drug Administration yesterday issued a warning letter to CanaRx, a company that contracts with employers to provide select prescription drugs to employees, for facilitating the distribution of unapproved and misbranded drugs.
Eight in 10 U.S. adults say prescription drug costs are “unreasonable,” and one in four say their prescription medicines are difficult to afford, according to the latest Kaiser Family Foundation Health Tracking Poll.
The Centers for Medicare & Medicaid Services will host a March 5 listening session on its proposed rule to promote electronic health information exchange.
Patients and their providers rely on these prescription drugs for treating injury and managing illness. Yet the drug companies and their shareholders have been treating America’s patients and providers like a piggybank.
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing to review what programs and strategies are working to address the opioid epidemic and where to focus future funding.
The House Education and Labor Committee’s Subcommittee on Workforce Protections yesterday held a hearing on protecting health care and social service workers from violence in the workplace.
The Centers for Medicare & Medicaid Services today updated its overall hospital quality star ratings at Hospital Compare and proposed future changes to the star ratings methodology in response to stakeholder feedback.
CMS has extended the deadline for hospitals participating in the Inpatient Quality Reporting and/or Promoting Interoperability Programs to submit data to receive a full payment update in fiscal year 2020.
The Centers for Medicare & Medicaid Services today published answers to frequently asked questions about Section 1332 State Relief and Empowerment Waiver pass-through funding.